| Pharmaceutical Information |
| Drug Name |
Delavirdine |
| Drug ID |
BADD_D00603 |
| Description |
A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. |
| Indications and Usage |
For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted |
| Marketing Status |
Prescription |
| ATC Code |
J05AG02 |
| DrugBank ID |
DB00705
|
| KEGG ID |
D07782
|
| MeSH ID |
D020008
|
| PubChem ID |
5625
|
| TTD Drug ID |
D0G6SD
|
| NDC Product Code |
Not Available |
| Synonyms |
Delavirdine | Rescriptor | U-90152 | U 90152 | U90152 | U-90152S | U 90152S | U90152S | Delavirdine Mesylate | Mesylate, Delavirdine |
|
| Chemical Information |
| Molecular Formula |
C22H28N6O3S |
| CAS Registry Number |
136817-59-9 |
| SMILES |
CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
